HERNEXEOS (zongertinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2 POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER W/ TYROSINE KINASE DOMAIN ACTIVATING MUTATIONS
Boehringer Ingelheim